AAAAAA
Results: 26-39/39
Authors:
Serebruany, VL
Gurbel, PA
Citation: Vl. Serebruany et Pa. Gurbel, Effect of thrombolytic therapy on platelet expression and plasma concentration of PECAM-1 (CD31) in patients with acute myocardial infarction, ART THROM V, 19(1), 1999, pp. 153-158
Authors:
Serebruany, VL
Yurovsky, VV
Gurbel, PA
Citation: Vl. Serebruany et al., Mild myocardial stunning affects platelet aggregation and certain hemostatic factors in swine, CL APPL T-H, 5(4), 1999, pp. 236-242
Authors:
Gurbel, PA
O'Connor, CM
Cummings, CC
Serebruany, VL
Citation: Pa. Gurbel et al., Clopidogrel: The future choice for preventing platelet activation during coronary stenting?, PHARMAC RES, 40(2), 1999, pp. 107-111
Authors:
Gurbel, PA
Murugesan, SR
Lowry, DR
Serebruany, VL
Citation: Pa. Gurbel et al., Plasma thromboxane and prostacyclin are linearly related and increased in patients presenting with acute myocardial infarction, PROS LEUK E, 61(1), 1999, pp. 7-11
Authors:
Serebruany, VL
Gurbel, PA
Citation: Vl. Serebruany et Pa. Gurbel, The relations of major platelet receptor expression during myocardial infarction. Monitoring efficacy of GPIIb/IIIa inhibitors by measuring P-selectin?, THROMB HAEM, 81(2), 1999, pp. 314-316
Authors:
Serebruany, VL
Kereiakes, DJ
Dalesandro, MR
Gurbel, PA
Citation: Vl. Serebruany et al., The flow cytometer model markedly affects measurement of ex vivo whole blood platelet-bound P-selectin expression in patients with chest pain: Are wecomparing apples with oranges?, THROMB RES, 96(1), 1999, pp. 51-56
Authors:
Murugesan, SR
Gurbel, PA
Serebruany, VL
Citation: Sr. Murugesan et al., Storing paraformaldehyde-fixed whole blood patient samples after chronic platelet glycoprotein IIb/IIIa blockade: Core laboratory considerations, THROMB RES, 95(4), 1999, pp. 201-203
Authors:
Serebruany, VL
Gurbel, PA
Citation: Vl. Serebruany et Pa. Gurbel, Assessment of platelet activity by measuring platelet-derived substances in plasma from patients with acute myocardial infarction: Surprising lessonsfrom the GUSTO-III platelet study, THROMB RES, 93(3), 1999, pp. 149-150
Authors:
Serebruany, VL
Yurovsky, VV
Gurbel, PA
Citation: Vl. Serebruany et al., Effects of a novel Mac-1 inhibitor, NPC 15669, on hemostatic parameters during preconditioned myocardial infarction, LIFE SCI, 65(14), 1999, pp. 1503-1513
Authors:
McKenzie, ME
Gurbel, PA
Levine, DJ
Serebruany, VL
Citation: Me. Mckenzie et al., Clinical utility of available methods for determining platelet function, CARDIOLOGY, 92(4), 1999, pp. 240-247
Authors:
McKenzie, ME
Pothula, A
Gurbel, PA
Fuzaylov, SY
O'Connor, CM
Gattis, WA
Serebruany, VL
Citation: Me. Mckenzie et al., Failure of thrombin generation markers to triage patients presenting with chest pain, CARDIOLOGY, 92(1), 1999, pp. 53-58
Authors:
Serebruany, VL
Murugesan, SR
Pothula, A
Semaan, H
Gurbel, PA
Citation: Vl. Serebruany et al., Soluble PECAM-1, but not P-selectin, nor osteonectin identify acute myocardial infarction in patients presenting with chest pain, CARDIOLOGY, 91(1), 1999, pp. 50-55
Authors:
Nair, GV
Gurbel, PA
O'Connor, CM
Gattis, WA
Murugesan, SR
Serebruany, VL
Citation: Gv. Nair et al., Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors, AM J CARD, 84(3), 1999, pp. 321
Authors:
O'Connor, CM
Gurbel, PA
Serebruany, VL
Citation: Cm. O'Connor et al., Usefulness of soluble and surface-bound P-selectin in detecting heightenedplatelet activity in patients with congestive heart failure, AM J CARD, 83(9), 1999, pp. 1345-1349